167 results on '"Masaki, Hiroya"'
Search Results
2. Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-β gene expression via transcriptional and post-transcriptional mechanisms
3. Soluble FcγRIIIaMϕ Levels in Plasma Correlate with Carotid Maximum Intima-Media Thickness (IMT) in Subjects Undergoing an Annual Medical Checkup
4. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis
5. Amelioration of diabetic peripheral neuropathy by implantation of hematopoietic mononuclear cells in streptozotocin-induced diabetic rats
6. Retraction: Transactivation of EGF receptor induced by angiotensin II regulates fibronectin and TGF-β gene expression via transcriptional and post-transcriptional mechanisms
7. A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure
8. Phospholamban deificiency alters inactivation kinetics of L-type Ca2+ channels in mouse ventricular myocytes
9. Increased Plasma S100A12 (EN-RAGE) Levels in Patients with Type 2 Diabetes
10. Effect Of Vasodilatory β-Adrenoceptor Blockers On Cardiovascular Haemodynamics In Anaesthetized Rats
11. Angiotensin II signaling and HB-EGF shedding via metalloproteinase in glomerular mesangial cells
12. The regulation of EN-RAGE (S100A12) gene expression in human THP-1 macrophages
13. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation
14. Initial Stage of SCC of Type 316L Stainless Steel in High Temperature and High Pressure Aqueous Solution
15. Cardiac-specific Overexpression of Angiotensin II AT2 Receptor Causes Attenuated Response to AT1 Receptor-mediated Pressor and Chronotropic Effects
16. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial
17. cAMP Responsive Element-mediated Regulation of the Gene Transcription of the alpha1B Adrenergic Receptor by Thyrotropin
18. Effect of Angiotensin II Type 2 Receptor on Tyrosine Kinase Pyk2 and c-Jun NH2-Terminal Kinase via SHP-1 Tyrosine Phosphatase Activity: Evidence from Vascular-Targeted Transgenic Mice of AT2 Receptor
19. Angiotensin II Initiates Tyrosine Kinase Pyk2-dependent Signalings Leading to Activation of Rac1-mediated c-Jun NH2-terminal Kinase
20. Interleukin-1βUpregulates Cardiac Expression of Vascular Endothelial Growth Factor and its Receptor KDR/flk-1 via Activation of Protein Tyrosine Kinases
21. Acute tubulointerstitial nephritis associated with autoimmune-related pancreatitis
22. Preliminary report: nephroscope-assisted “pulling-thread” technique for placement of peritoneal dialysis catheter
23. A Novel Frameshift Mutation in Exon 4 Causing a Deficiency of High-molecular-weight Kininogen in a Patient with Splenic Infarction
24. Epidemiology of Enterobacteriaceae strains producing extended-spectrum β-Lactamases from blood cultures in Kansai Medical University Takii Hospital
25. Distance optimization approach to ratio-form efficiency measures in data envelopment analysis
26. 940 COMBINED EFFECTS OF ANGIOTENSIN II RECEPTOR ANTAGONIST AND CALCIUM CHANNEL BLOCKER IN HYPERTENSIVE PATIENTS WITH TYPE 2 DIABETES-
27. Comparison between Two Calcium Antagonists: Blood Pressure Reduction and Renal Effects in Hypertensive Patients with Type 2 Diabetes
28. Corrigendum to “Effect of angiotensin II type 2 receptor on tyrosine kinase Pyk2 and c-jun NH2-terminal kinase via SHP-1 tyrosine phosphatase activity: Evidence from vascular-targeted transgenic mice of AT2 receptor” [Biochem. Biophys. Res. Commun. 282 (2001) 1085–1091]
29. Pitavastatin Further Decreases Serum High-Sensitive C-Reactive Protein Levels in Hypertensive Patients with Hypercholesterolemia Treated with Angiotensin II, Type-1 Receptor Antagonists
30. Anti-Aquaporin-4 Antibody-Positive Optic Neuritis Treated with Double-Filtration Plasmapheresis
31. Nihon Toseki Igakkai Zasshi
32. Crystallographic characterization of stress corrosion cracking initiation on type316L stainless steel in high temperature and high pressure water
33. A Case Report of Interferon ? Monotherapy for High Hepatitis C Viral Load in Dialysis Patients
34. Novel Digitalis-Like Factor, Marinobufotoxin, Isolated From Cultured Y-1 Cells, and Its Hypertensive Effect in Rats
35. ‘Takotsubo’ Cardiomyopathy in a Maintenance Hemodialysis Patient
36. Rate of Helicobacter pylori (H. pylori) infection in hemodialysis patients
37. Targeted Delivery of Bone Marrow Mononuclear Cells by Ultrasound Destruction of Microbubbles Induces Both Angiogenesis and Arteriogenesis Response
38. Assessment of Coronary Artery Disease in Hemodialysis Patients with Delayed Systolic Blood Pressure Response after Exercise Testing
39. The clinical effect of a traditional herbal formula, Juzen-Taiho-to, in hemodialysis patients
40. Impact of the Angiotensin II Receptor Antagonist, Losartan, on Myocardial Fibrosis in Patients with End-Stage Renal Disease: Assessment by Ultrasonic Integrated Backscatter and Biochemical Markers
41. Continuous ambulatory peritoneal dialysis (CAPD) therapy for an end-stage renal disease (ESRD) patient with nephrotic syndrome
42. Somatic Stem Cell Therapy for Cardiovascular Diseases
43. Effect Of Vasodilatory beta-Adrenoceptor Blockers On Cardiovascular Haemodynamics In Anaesthetized Rats
44. Ileocecal angiodysplasia in a patient with chronic renal failure: Case report and review of the Japanese literature.
45. Angiotensin II Type 1 Receptor Antagonist, Losartan, Causes Regression of Left Ventricular Hypertrophy in End-Stage Renal Disease
46. Angiotensin II Type 2 Receptor Inhibits Epidermal Growth Factor Receptor Transactivation by Increasing Association of SHP-1 Tyrosine Phosphatase
47. Implantation of Bone Marrow Mononuclear Cells Into Ischemic Myocardium Enhances Collateral Perfusion and Regional Function via Side Supply of Angioblasts, Angiogenic Ligands, and Cytokines
48. Apoptosis Is Not Increased in Myocardium Overexpressing Type 2 Angiotensin II Receptor in Transgenic Mice
49. Angiotensin AT 1 and AT 2 Receptors Differentially Regulate Angiopoietin-2 and Vascular Endothelial Growth Factor Expression and Angiogenesis by Modulating Heparin Binding–Epidermal Growth Factor (EGF)–Mediated EGF Receptor Transactivation
50. Safety and Availability of Doxazosin in Treating Hypertensive Patients with Chronic Renal Failure.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.